Literature DB >> 15602657

Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids.

J A González-Correa1, M M Arrebola, I M Ureña, D Ruiz-Villafranca, J Muñoz-Marín, A Guerrero, F Sánchez de la Cuesta, J P De La Cruz.   

Abstract

Triflusal is a fluorinated derivative of acetylsalicylic acid (ASA) with demonstrated antithrombotic activity. Recently, evidence for a neuroprotective effect has been obtained. The aim of this study was to compare the neuroprotective effects of the main metabolite of triflusal (2-hydroxy-4-trifluoromethylbenzoic acid, HTB) and the ASA metabolite salicylic acid (SA) in an in vitro model of anoxia-reoxygenation in rat brain slices. Rat brain slices (n=10 per group) were subjected to a period of anoxia followed by 180 min reoxygenation. We measured oxidative stress parameters (lipid peroxidation, glutathione system), prostaglandins (PGE(2)), nitric oxide pathway activity (NO) (nitrites+nitrates, constitutive and inducible NO synthase activity) and LDH efflux, a biochemical marker of cell death. Various concentrations (10, 100 and 1,000 microM) of triflusal, HTB, ASA or SA were tested. Triflusal at 10, 100 and 1,000 microM decreased LDH efflux in rat brain slices after anoxia/reoxygenation by 24%, 35% and 49% respectively. This effect was proportionately greater than that of ASA (0%, 13% and 32%). The results with HTB were similar to those with triflusal, whereas SA showed a greater protective effect than ASA (13%, 33% and 35%). The antioxidant effects of HTB and SA on the biochemical mechanisms of cell damage studied here were also greater than the effects of triflusal and ASA, a finding attributable mainly to the decrease in lipid peroxidation and to the ability of HTB to also increase glutathione levels. The triflusal metabolite reduced inducible NO synthase activity by 18%, 21% and 30%, whereas SA inhibited this activity by 9%, 17% and 23%. Triflusal and HTB led to greater increases in NO synthase than ASA or AS. In conclusion, the metabolite HTB plays an important role in the neuroprotective effect of triflusal, at least in the experimental model of anoxia-reoxygenation tested here.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15602657     DOI: 10.1007/s00210-004-1001-y

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  Comparison of in vitro effects of triflusal and acetysalicylic acid on nitric oxide synthesis by human neutrophils.

Authors:  L Sánchez de Miguel; S Casado; J Farré; M García-Durán; L A Rico; M Montón; J Romero; T Bellver; M P Sierra; J I Guerra; P Mata; A Esteban; A López-Farré
Journal:  Eur J Pharmacol       Date:  1998-02-05       Impact factor: 4.432

2.  Glutathione transferases from human liver.

Authors:  M Warholm; C Guthenberg; C von Bahr; B Mannervik
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

3.  Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients.

Authors:  J P De la Cruz; J Pavia; J Garcia-Arnes; F Sanchez de la Cuesta
Journal:  Eur J Haematol       Date:  1988-03       Impact factor: 2.997

4.  Enhanced iNOS function in myocytes one day after brief ischemic episode.

Authors:  Song-Jung Kim; Young-Kwon Kim; Gen Takagi; Cheng-Hsiung Huang; Yong-Jian Geng; Stephen F Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

5.  Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase.

Authors:  J P de la Cruz; J M Mata; F Sanchez de la Cuesta
Journal:  Gen Pharmacol       Date:  1992-03

Review 6.  Brain protection: physiological and pharmacological considerations. Part I: The physiology of brain injury.

Authors:  J Murdoch; R Hall
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

7.  Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway.

Authors:  J P De La Cruz; E Blanco; F Sánchez de la Cuesta
Journal:  Eur J Pharmacol       Date:  2000-05-26       Impact factor: 4.432

8.  Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial.

Authors:  Jordi Matías-Guiu; José M Ferro; José Alvarez-Sabín; Ferran Torres; M Dolores Jiménez; Aida Lago; Teresa Melo
Journal:  Stroke       Date:  2003-03-20       Impact factor: 7.914

9.  Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1.

Authors:  A López-Farré; C Caramelo; A Esteban; M L Alberola; I Millás; M Montón; S Casado
Journal:  Circulation       Date:  1995-04-01       Impact factor: 29.690

10.  Antioxidant effects of a single dose of acetylsalicylic acid and salicylic acid in rat brain slices subjected to oxygen-glucose deprivation in relation with its antiplatelet effect.

Authors:  A Guerrero; J A González-Correa; M M Arrebola; J Muñoz-Marín; F Sánchez de la Cuesta; J P de la Cruz
Journal:  Neurosci Lett       Date:  2004-04-01       Impact factor: 3.046

View more
  2 in total

Review 1.  Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation.

Authors:  David Murdoch; Greg L Plosker
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Lack of enantiomeric influence on the brain cytoprotective effect of ibuprofen and flurbiprofen.

Authors:  J A López-Villodres; J P De La Cruz; J Muñoz-Marin; A Guerrero; J J Reyes; J A González-Correa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-06-29       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.